FDA approves first treatment for chronic hepatitis delta virus infection

Medical Xpress

The U.S.

Food and Drug Administration has approved Hepcludex (bulevirtide‐gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or compensated cirrhosis.

Approval of Hepcludex was granted to Gilead Sciences. ...

전문 보기

관련 뉴스

관련 뉴스 제보는 로그인 후 가능합니다.

'science' 카테고리 뉴스

Ebola outbreak in Central Africa could reach 20,000 cases without strong public health measures

Medical Xpress

The World Cup pitches are the result of years of engineering to find just the right grass

Phys.org

First AI-designed 'universal vaccine' tested in humans: UK researchers

Medical Xpress

Medical Xpress의 다른 기사

RFK Jr. seeks to peek at Americans' medical records for clues on autism and vaccines

Medical Xpress

Brain surgery for pituitary tumor helps Illinois mom have second baby

Medical Xpress

'We need to rethink what is safe when it comes to parental alcohol use,' say experts

Medical Xpress